Christianson Gary 4
4 · Cascadian Therapeutics, Inc. · Filed Sep 20, 2017
Insider Transaction Report
Form 4
Christianson Gary
Chief Operating Officer
Transactions
- Award
Restricted Share Unit (RSU)
2017-09-18+15,000→ 15,000 totalExp: 2021-09-18→ Common Stock (15,000 underlying) - Award
Stock Option (right to buy)
2017-09-18+68,000→ 68,000 totalExercise: $3.99Exp: 2027-09-18→ Common Stock (68,000 underlying)
Footnotes (3)
- [F1]The option vests and is exercisable at the rate of 1/4th of the total shares on September 18, 2018 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on September 18, 2021, subject to the holder's continued employment with the issuer on each vesting date.
- [F2]Approximately 67% of each RSU represents a contingent right to receive approximately 0.67 share of the issuer's Common Stock upon vesting and approximately 33% represents a contingent right to receive cash upon vesting, which cash will be used to facilitate the holder's satisfaction of U.S. federal tax obligations in connection with the vesting of the RSUs.
- [F3]Twenty-five percent of the shares underlying the RSU vest on each of September 18, 2018, September 18, 2019, September 18, 2020 and September 18, 2021, subject to the holder's continued employment with the issuer on each vesting date.